CONCENTRATIONS (Details)	12 Months Ended
	Dec. 31, 2022 USD ($) Customer	Dec. 31, 2021 USD ($) Customer
Risks and Uncertainties [Abstract]
Plasma purchased from Grifols | $	$ 47,700,000	$ 42,000,000
Percentage of inventory purchases	65.00%	69.00%
Segment Reporting Information [Abstract]
Revenues | $	$ 154,079,692	$ 80,942,625
United States [Member]
Segment Reporting Information [Abstract]
Revenues | $	146,426,617	70,625,848
International [Member]
Segment Reporting Information [Abstract]
Revenues | $	$ 7,653,075	$ 10,316,777
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Two Customers [Member]
Risks and Uncertainties [Abstract]
Number of customers | Customer	2
Concentration risk, percentage	92.00%
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Three Customers [Member]
Risks and Uncertainties [Abstract]
Number of customers | Customer		3
Concentration risk, percentage		94.00%
Revenue [Member] | Customer Concentration Risk [Member] | Two Customers [Member]
Risks and Uncertainties [Abstract]
Number of customers | Customer	2
Concentration risk, percentage	74.00%
Revenue [Member] | Customer Concentration Risk [Member] | Four Customers [Member]
Risks and Uncertainties [Abstract]
Number of customers | Customer		4
Concentration risk, percentage		81.00%